Key result
TAVR had a similar incidence of prosthetic valve endocarditis compared to SAVR.
Why the study?
Prosthetic valve endocarditis is a rare but critical cause of valve failure and death after TAVR and SAVR, warranting further analysis of its incidence, risk factors, and outcomes in modern experience.
Does TAVR compared to SAVR alter the incidence of prosthetic valve endocarditis in patients with severe aortic stenosis?
Cohort (n=8,530)
Yes
Does TAVR compared to SAVR alter the incidence of prosthetic valve endocarditis in patients with severe aortic stenosis?
Prosthetic valve endocarditis remains a rare but highly fatal complication after aortic valve replacement, with no significant difference in incidence, predictors, or temporal risk between TAVR and SAVR.
Answers are grounded in this paper and cite their sources.
Similar endocarditis rates should not yet influence TAVR versus SAVR selection; leaves open need for randomized confirmation.
Background: Prosthetic valve endocarditis (PVE) is a rare but critical mechanism of valve failure and death after transcatheter and surgical aortic valve replacement (TAVR, SAVR) warranting further analysis in modern aortic valve replacement experience. We characterize the incidence, risk factors, microbiological profile and outcomes of PVE from the PARTNER trials and registries (Placement of Aortic Transcatheter Valve). Methods: We analyzed a pooled cohort of all patients in PARTNER 1 and PARTNER 2 trials and registries. Patients had severe aortic stenosis, were treated with TAVR or SAVR, and were analyzed with respect to development of PVE. PVE adjudication by a clinical events committee was based on modified Duke Criteria. The incidence, infection timing, organism, and association between PVE and all-cause mortality were analyzed. Results: 8530 patients were included. PVE occurred in 107 cases (5.06 PVE events per 1000 person-years over a mean follow-up of 2.69±1.55 years [95% CI, 4.19–6.12]). The incidence of TAVR-PVE (5.21 PVE per 1000 person-years [95% CI, 4.26–6.38]) was not significantly different from SAVR-PVE (4.10 per 1000 person-years [95% CI, 2.33–7.22]; incident rate ratio, 1.27 [95% CI, 0.70–2.32]; P =0.44). Temporal risk of PVE was similar for TAVR and SAVR, even after adjusting for competing risk of death (hazard ratio, 1.15 [95% CI, 0.58–2.28]; P =0.69). Through multivariable analysis, PVE was associated with baseline cirrhosis (incident rate ratio, 2.86 [95% CI, 1.33–6.16]; P =0.007), pulmonary disease (incident rate ratio, 1.70 [95% CI, 1.16–2.48]; P =0.006), and renal insufficiency (incident rate ratio, 1.71 [95% CI, 1.03–2.83]; P =0.04). Timing of PVE was similar between TAVR and SAVR (<30 days: 4.2% vs 8.3%; 31 days to 1 year: 52.6% vs 66.7%; >1 year: 43.2% vs 25.0%; P =0.28). Staphylococcus occurred more commonly after SAVR (58.3% vs 28.4% in TAVR; P =0.04). PVE was strongly associated with all-cause mortality after endocarditis diagnosis (hazard ratio, 4.4 [95% CI, 3.42–5.72]; P <0.0001). Conclusions: The widespread adoption of TAVR and application to lower-risk patients makes understanding mechanisms of valve failure increasingly important. PVE is an established mechanism of prosthetic valve failure post-SAVR and TAVR with unclear differences between approaches. We herein demonstrate in the largest trials and registries of TAVR that PVE remains rare, but often fatal, in modern AVR experience and that there is no difference in incidence, predictors, or risk of PVE between TAVR and SAVR. Clinical Trial Registration: https://www.clinicaltrials.gov . Unique identifiers: NCT00530894 (PARTNER 1), NCT01314313 (PARTNER 1IA), NCT02184442 (PARTNER 1IB), NCT03222141 (PII S3HR), NCT03222128 (PII S3i).
No takes yet. Share an insight, caveat, or question.
Summers et al. (2019) conducted a cohort in Severe aortic stenosis (n=8,530). TAVR vs. SAVR was evaluated on Incidence of prosthetic valve endocarditis (PVE) (incident rate ratio 1.27, 95% CI 0.70-2.32, p=0.44). TAVR had a similar incidence of prosthetic valve endocarditis compared to SAVR.
Synapse has enriched 10 related papers. Consider them for comparative context: